• G&E Healthcare received notice on Oct. 28, 2026, of potential designation as a disclosure-rule violator under KONEX regulations.
• The company bought back fewer shares by value than disclosed July 9, 2026, with the reversal disclosed Oct. 16, 2026.
• A designation decision is due Nov. 18, 2026. The company had no disclosure penalty points over the preceding year.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. G&E Healthcare Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261028600707), on October 28, 2026, and is solely responsible for the information contained therein.